Telmisartan improves vascular function and reduces platelet activation in rats with streptozotocin-induced diabetes mellitus
- 30 September 2007
- journal article
- Published by Elsevier BV in Pharmacological Research
- Vol. 56 (3), 217-223
- https://doi.org/10.1016/j.phrs.2007.05.009
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Blockade of the renin–angiotensin–aldosterone system: a key therapeutic strategy to reduce renal and cardiovascular events in patients with diabetesJournal Of Hypertension, 2006
- Reduced Vascular NO Bioavailability in Diabetes Increases Platelet Activation In VivoArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Rapid Regulation of Platelet Activation In Vivo by Nitric OxideCirculation, 2004
- Diabetes and Progression of Carotid AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- A Critical Role of Platelet Adhesion in the Initiation of Atherosclerotic Lesion FormationThe Journal of Experimental Medicine, 2002
- Elevated Risk of Cardiovascular Disease Prior to Clinical Diagnosis of Type 2 DiabetesDiabetes Care, 2002
- Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololThe Lancet, 2002
- Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 DiabetesNew England Journal of Medicine, 2001
- Nitric Oxide Insufficiency, Platelet Activation, and Arterial ThrombosisCirculation Research, 2001
- Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial InfarctionNew England Journal of Medicine, 1998